ARCUTIS BIOTHERAPEUTICS INC. - COMMON STOCK
10.14
22-November-24 16:44:58
15 minutes delayed
Stocks
-0.10
-0.98%
Today's range
10.05 - 10.37
ISIN
N/A
Source
NASDAQ
-
Arcutis’ ZORYVE® (roflumilast) Awarded Best Eczema Treatment by Glamour
13 Nov 2024 08:00:00 By Nasdaq GlobeNewswire
-
Arcutis Announces Third Quarter 2024 Financial Results and Provides Business Update
06 Nov 2024 16:00:00 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Nov 2024 16:00:00 By Nasdaq GlobeNewswire
-
23 Oct 2024 16:00:00 By Nasdaq GlobeNewswire
-
18 Oct 2024 08:20:14 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Oct 2024 16:00:00 By Nasdaq GlobeNewswire
-
25 Sep 2024 01:00:00 By Nasdaq GlobeNewswire
-
24 Sep 2024 08:00:00 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Sep 2024 16:00:00 By Nasdaq GlobeNewswire
-
Arcutis Completes Enrollment of Phase 1b Alopecia Areata Study Evaluating ARQ-255
05 Sep 2024 08:00:00 By Nasdaq GlobeNewswire
-
Arcutis to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
22 Aug 2024 08:00:00 By Nasdaq GlobeNewswire
-
CORRECTION – Arcutis Announces Second Quarter 2024 Financial Results and Provides Business Update
14 Aug 2024 21:00:03 By Nasdaq GlobeNewswire
-
Arcutis Announces Second Quarter 2024 Financial Results and Provides Business Update
14 Aug 2024 16:00:00 By Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Aug 2024 16:00:00 By Nasdaq GlobeNewswire
-
Arcutis to Report Second Quarter 2024 Financial Results and Host Conference Call on August 14, 2024
01 Aug 2024 16:00:00 By Nasdaq GlobeNewswire
-
Arcutis Announces ZORYVE® U.S. Co-promote Agreement with Kowa Pharmaceuticals America, Inc.
29 Jul 2024 07:35:00 By Nasdaq GlobeNewswire
-
Arcutis Launches ZORYVE® (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis
29 Jul 2024 07:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >